[Lysis from without of a culture of Actinomyces griseus--producer of the antibiotic kormogrizein]. 1977

Ia I Rautenshteĭn, and V V Zhunaeva, and N Ia Solov'eva

A polylysogenic culture of Actinomyces griseus 15 producing the antibiotic cormogrisin is sensitive to actinophages, denoted as types 15 I, 15 II and 15 III, which are the virulent mutants of its temperate phages. In certain cases, the variants of Act. griseus 15, obtained by selection and resistant to the phages types 15 I and 15 II, can undergo lysis-from-without by these phages. A study of the mechanisms involved in this phenomenon has shown that the lytic activity is entirely eliminated if the phages have been a titre of 10(9) and higher. The lytic activity is entirely eliminated if the phages have been treated with a specific serum or inactivated by UV. The variants resistant to phage 15 I can adsorb this phage and undergo lysis-from-without at a high multiplicity of infection if only the age of the variant does not exceed 13 hours. The variants resistant to phages 15 I and 15 II can undergo lysis-from-within under the action of phage 15 III. The variants resistant to this phage have acquired this resistance as a result of lysogenization. They have entirely retained the ability to adsorb phage 15 I, but their ability to absorb phage 15 III is much lower. Therefore, the rate of mycelium growth is only slightly inhibited, but the lysis of the culture is not observed, under the action of phage 15 III having titres of 10(9) and 10(10).

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D008242 Lysogeny The phenomenon by which a temperate phage incorporates itself into the DNA of a bacterial host, establishing a kind of symbiotic relation between PROPHAGE and bacterium which results in the perpetuation of the prophage in all the descendants of the bacterium. Upon induction (VIRUS ACTIVATION) by various agents, such as ultraviolet radiation, the phage is released, which then becomes virulent and lyses the bacterium. Integration, Prophage,Prophage Integration,Integrations, Prophage,Prophage Integrations
D005615 Freezing Liquids transforming into solids by the removal of heat. Melting
D001435 Bacteriophages Viruses whose hosts are bacterial cells. Phages,Bacteriophage,Phage
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D013305 Streptomyces griseus An actinomycete from which the antibiotics STREPTOMYCIN, grisein, and CANDICIDIN are obtained.
D014466 Ultraviolet Rays That portion of the electromagnetic spectrum immediately below the visible range and extending into the x-ray frequencies. The longer wavelengths (near-UV or biotic or vital rays) are necessary for the endogenous synthesis of vitamin D and are also called antirachitic rays; the shorter, ionizing wavelengths (far-UV or abiotic or extravital rays) are viricidal, bactericidal, mutagenic, and carcinogenic and are used as disinfectants. Actinic Rays,Black Light, Ultraviolet,UV Light,UV Radiation,Ultra-Violet Rays,Ultraviolet Light,Ultraviolet Radiation,Actinic Ray,Light, UV,Light, Ultraviolet,Radiation, UV,Radiation, Ultraviolet,Ray, Actinic,Ray, Ultra-Violet,Ray, Ultraviolet,Ultra Violet Rays,Ultra-Violet Ray,Ultraviolet Black Light,Ultraviolet Black Lights,Ultraviolet Radiations,Ultraviolet Ray
D014644 Genetic Variation Genotypic differences observed among individuals in a population. Genetic Diversity,Variation, Genetic,Diversity, Genetic,Diversities, Genetic,Genetic Diversities,Genetic Variations,Variations, Genetic

Related Publications

Ia I Rautenshteĭn, and V V Zhunaeva, and N Ia Solov'eva
October 1949, Comptes rendus hebdomadaires des seances de l'Academie des sciences,
Ia I Rautenshteĭn, and V V Zhunaeva, and N Ia Solov'eva
June 1974, Antibiotiki,
Ia I Rautenshteĭn, and V V Zhunaeva, and N Ia Solov'eva
June 1948, Comptes rendus hebdomadaires des seances de l'Academie des sciences,
Ia I Rautenshteĭn, and V V Zhunaeva, and N Ia Solov'eva
January 1975, Mikrobiologiia,
Ia I Rautenshteĭn, and V V Zhunaeva, and N Ia Solov'eva
March 1965, Antibiotiki,
Ia I Rautenshteĭn, and V V Zhunaeva, and N Ia Solov'eva
April 1972, Antibiotiki,
Ia I Rautenshteĭn, and V V Zhunaeva, and N Ia Solov'eva
October 1949, Comptes rendus hebdomadaires des seances de l'Academie des sciences,
Ia I Rautenshteĭn, and V V Zhunaeva, and N Ia Solov'eva
May 1975, Antibiotiki,
Ia I Rautenshteĭn, and V V Zhunaeva, and N Ia Solov'eva
August 1968, Antibiotiki,
Copied contents to your clipboard!